Novacyt H1 Revenues Down 15 Percent Amid SARS-CoV-2 Contract Dispute - NewsBreak

NEW YORK — Novacyt on Monday reported a nearly 15 percent year-over-year decrease in revenues for the first half of 2021 as the French diagnostics firm held off on including revenues generated under a disputed SARS-CoV-2 test supply contract with the UK Department of Health and Social Care (DHSC). For...